UCSF

Scangos named CEO of Biogen Idec

George Scangos, PhD, a member of the UCSF School of Pharmacy Board of Advisors, has been appointed chief executive officer (CEO) of the global biotechnology company Biogen Idec, which is headquartered in Cambridge, Massachusetts, and Zug, Switzerland. The appointment is effective July 15, 2010. Scangos brings to the company more than 25 years of experience in the biotechnology and pharmaceutical industries. He has served, since 1996, as president and CEO of the South San Francisco-based biotechnology company Exelixis, Inc. after leadership roles at Bayer Corporation. Scangos earned his PhD in microbiology from the University of Massachusetts.

Press release

[Biogen Idec Names George Scangos Chief Executive Officer][link defunct as of July 13, 2013]

Conference call and interview session

[Biogen Idec Inc. Names George Scangos Chief Executive Officer (requires registration)][link defunct as of September 24, 2010]


About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.